Skip to main content
Robert Negrin, MD, Hematology, Stanford, CA, Stanford Health Care

RobertSNegrinMD

Hematology Stanford, CA

Professor, Medicine - Blood & Marrow Transplantation, Stanford University Medical Center

Dr. Negrin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Negrin's full profile

Already have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Neonatal-Perinatal Medicine, 1988 - 1989
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 1987 - 1988
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1984 - 1987
  • Harvard Medical School
    Harvard Medical SchoolClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1985 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Activation of Regulatory T Cells with IL-2 and TNF-_ to Promote Homing to the Gut and to Improve Acute GvHD Prevention
    Robert S. Negrin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Improved Outcomes for Relapsed/Refractory Classic Hodgkin Lymphoma Following Autologous Stem Cell Transplantation in the Era of Novel Agents
    Robert S. Negrin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Allogeneic Chimeric Antigen Receptor-Invariant Natural Killer T Cells Exert Both Direct and Indirect Antitumor Effects through Host CD8 T Cell Cross-Priming
    Robert S. Negrin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • How to Peer Review a Scientific Paper 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Volunteering Your Skills Overseas 
    60th American Society of Hematology Annual Meeting - 11/30/2018

Other

Press Mentions

  • Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood Cancers
    Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 2nd, 2021
  • Orca Bio Announces Oral Presentation of Orca-T Clinical Data at the 62nd American Society of Hematology (ASH) Annual Meeting
    Orca Bio Announces Oral Presentation of Orca-T Clinical Data at the 62nd American Society of Hematology (ASH) Annual MeetingNovember 4th, 2020
  • ASH Launches Digital, Open-Access Journal
    ASH Launches Digital, Open-Access JournalNovember 29th, 2016
  • Join now to see all

Grant Support

  • Role Of Regulatory T Cells In GVHD, Gvt, And Tolerance InductionNational Heart, Lung, And Blood Institute2010–2011
  • HematopoeticNational Cancer Institute2010–2011
  • NK Cells In GVHD And GVTNational Cancer Institute2008–2011
  • Control Of GVHD With Retained GVTNational Cancer Institute2007–2011
  • Allografting For LukemiaNational Cancer Institute2007–2011
  • Training Program In Hematopoietic Cell TransplantationNational Heart, Lung, And Blood Institute2001–2011
  • Bone Marrow Grafting For Leukemia And LymphomaNational Cancer Institute2000–2011
  • Regulatory T Cells In Allogeneic TransplantationNational Heart, Lung, And Blood Institute2009–2010
  • Prog 8- Hematopoietic Cell Transplantation AndNational Cancer Institute2007–2009
  • Regulatory T Cells Which Allow GVT Without GVHDNational Heart, Lung, And Blood Institute2004–2008
  • Administration And Research CoordinationNational Cancer Institute2007
  • Visualizing Tumors And Mechanisms Of Therapy In VivoNational Cancer Institute1999–2007
  • BMT Clinical Trial Network At StanfordNational Heart, Lung, And Blood Institute2002–2003
  • Allografting For LeukemiaNational Cancer Institute2002
  • Cytokine Induced Killer Cells After Autologous/Allogenic Marrow TransplantationNational Cancer Institute1997–2002
  • BMT Clinical Trial Netwrok At StanfordNational Heart, Lung, And Blood Institute2001

Professional Memberships

Hospital Affiliations